Skip to main content

Table 1 Baseline measures for patients according to the four different tobacco consumption habits (n = 128)

From: Is smokeless tobacco a healthier option in patients with AUD? A follow-up study during treatment

 

No tobacco n = 14 (11)

Smoke 75 (59)

Snus 19 (15)

Dual 20 (16)

Overall

No v smk

No v snus dual

No v dual

n = 14 (11%)

75 (59%)

19 (15%)

20 (16%)

p

p

p

p

Socio-demographics

Sex (female) n (%)

7 (50)

22 (29)

4 (21)

1 (5)

0.019*

0.212*

0.136*

0.004*

Years of age (median, IQR)

57.1 (51.5–58.8)

53.8 (46.8–58.2)

42.9 (33.3–51.7)

40.7 (32.4–53.7)

 < 0.001

0.329

0.018

0.009

Education (> upper secondary) n (%)

12 (100)

33 (60)

12 (92)

10 (71)

0.007*

0.006*

1.000*

0.100*

History of tobacco use

Smoked before n (%)

5 (36)

7 (37)

0.947

Used snus before n (%)

1 (8)

9 (12)

1.000*

Somatic health

BMI (median, IQR)

27.2 (25.6–31.7)

26.1 (22.9–29.3)

26.7 (22.4–28.7)

27.5 (25.1–29.1)

0.429

0.198

0.258

0.555

Waist measure (median, IQR)

95 (91–113)

102 (90–110)

99 (88–105)

102 (94–111)

0.763

0.727

0.356

0.927

Lifestyle

Low level of physical activity n (%)

5 (45)

34 (64)

4 (31)

8 (57)

0.152*

0.315*

0.675*

0.561

Mental health

Current major depression n (%)

2 (14)

12 (16)

3 (17)

5 (25)

0.790*

1.000*

1.000*

0.672*

Substance use related measures

Severity of dependence (median, IQR)

11 (10–12)

10 (7–12)

8 (1–10)

10 (7–11)

0.047

0.131

0.002

0.126

Alcohol use disorder n (%)

12 (100)

56 (90)

13 (81)

13 (81)

0.287*

0.581*

0.238*

0.238*

Other substance use disorder n (%)

1 (8)

13 (21)

5 (31)

9 (56)

0.019*

0.442*

0.196*

0.016*

  1. Statistical significance of group differences was assessed with Kruskal–Wallis and Mann–Whitney tests for continuous variables. Chi square test and Fischer’s exact test* (expected cell count < 5) were used to test group differences of categorical variables. The significance level was set 0.05 (bold)